← Top Holdings
BBIOBRIDGEBIO PHARMA INC
CUSIP: 10806X102
3
Guru Owners
$902.1M
Total Value Held
12.1M
Total Shares
| Investor | Fund | Shares | Value▼ | % of Portfolio | Rpt Price | Period |
|---|---|---|---|---|---|---|
| Viking Global Investors | 11842434 | $879.4M | 2.46% | $74.26 | Q1 2026 | |
| Bridgewater Associates | 259459 | $19.3M | 0.09% | $74.26 | Q1 2026 | |
| Polen Capital Management | 45934 | $3.4M | 0.02% | $74.26 | Q1 2026 |
📊 Fundamentals
Market Cap$15.3B
Forward P/E143.5x
EPS (TTM)$-3.75
Revenue (TTM)$580.0M
Profit Margin-124.42%
Beta0.95
52-Week Range
$42.09
$84.94
Current: $77.91
Data from Yahoo Finance · refreshed every 4 hours
📊 Holdings Over Time
How superinvestor ownership has changed across quarters
Quarter-by-Quarter Activity
Q1 '263 owners · $902.1M
Q4 '253 owners · $1.11B
Q3 '252 owners · $831.8M
Q2 '252 owners · $802.8M
Q1 '252 owners · $762.5M
Q4 '241 owners · $689.3M
No changes
💰 DCF Calculator
DCF model · 10-yr forecastEstimates depend entirely on your assumptions. Adjust the inputs below to explore scenarios.
⚠️ This company currently has negative free cash flow. The valuation assumes it will improve.
📊 Adjust the assumptions below to calculate an estimated fair value
Projection Period
Revenue Growth Rate
66%analyst est. 66.1%
0%100%
Growth Decay Rate
15%
0% (no decay)50% (fast decay)
Terminal Growth Rate
3.0%
0%5%
FCF Margin
5.0%current: -54.8%
1%50%
Discount Rate (WACC)
8.0%typical: 8% large caps · 10% growth
5%20%
Model: 10-year DCF · 3.0% terminal growth · Based on Yahoo Finance data
🏛️ Congressional Trades
BBIO: Held by 3 superinvestors · 1 congress member trade
$1,001 - $15,0002025-08-08